What Jazz Pharmaceuticals plc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 19 | 66 |
| Total trades | 51 | 161 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 161 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Cozadd Bruce C | Director | Nov 06 | Sale for tax withholding · S | −5,923 | $237.39 | −$1.41M | 357,567 |
| Cozadd Bruce C | Director | Nov 06 | Sale for tax withholding · S | −24,483 | $236.84 | −$5.8M | 363,490 |
| Cozadd Bruce C | Director | Nov 06 | Sale for tax withholding · S | −10,688 | $235.82 | −$2.52M | 387,973 |
| Cozadd Bruce C | Director | Nov 06 | Sale for tax withholding · S | −27,714 | $234.91 | −$6.51M | 398,661 |
| Cozadd Bruce C | Director | Nov 06 | Exercise / conversion · M | +85,766 | $136.18 | +$11.7M | 426,375 |
| Cozadd Bruce C | Director | Nov 06 | Exercise / conversion · M | +734 | $136.18 | +$100K | 340,609 |
| Carr Patricia | SVP, Chief Accounting Officer | Nov 04 | Open-market sale · S | −163 | $231.27 | −$37.7K | 6,512 |
| Carr Patricia | SVP, Chief Accounting Officer | Nov 04 | Open-market sale · S | −1,250 | $231.37 | −$289K | 6,675 |
| Carr Patricia | SVP, Chief Accounting Officer | Nov 04 | Exercise / conversion · M | +1,250 | $140.03 | +$175K | 7,925 |
| Gala Renee D | President & CEO | Nov 03 | Open-market sale · S | −1,000 | $225.37 | −$225K | 140,394 |
| Cozadd Bruce C | Director | Nov 02 | Open-market sale · S | −6,000 | $215.84 | −$1.3M | 339,875 |
| Gala Renee D | President & CEO | Oct 06 | Open-market sale · S | −2,000 | $236.40 | −$473K | 141,394 |
| Cozadd Bruce C | Director | Oct 01 | Open-market sale · S | −6,000 | $230.33 | −$1.38M | 345,875 |
| Patil Neena M | EVP & Chief Legal Officer | Sep 10 | Open-market sale · S | −1,200 | $240.94 | −$289K | 47,671 |
| Henderson Mary Elizabeth | SVP, Technical Operations | Sep 08 | Withheld — tax / exercise cost · F | −15 | $241.20 | −$3.62K | 23,815 |
| Gala Renee D | President & CEO | Sep 08 | Open-market sale · S | −2,000 | $243.03 | −$486K | 143,394 |
| Gala Renee D | President & CEO | Sep 08 | Withheld — tax / exercise cost · F | −1,967 | $246.81 | −$485K | 145,394 |
| Henderson Mary Elizabeth | SVP, Technical Operations | Sep 08 | Withheld — tax / exercise cost · F | −1,412 | $243.03 | −$343K | 23,830 |
| Cozadd Bruce C | Director | Sep 01 | Open-market sale · S | −6,000 | $250.13 | −$1.5M | 351,875 |
| Winningham Rick E | Director | Aug 31 | Withheld — tax / exercise cost · F | −14 | $244.64 | −$3.43K | 9,466 |
Loading...